サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1429919

プレシジョンメディシンの世界市場レポート 2024

Precision Medicine Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
プレシジョンメディシンの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

プレシジョンメディシンの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には9.9%の年間複合成長率（CAGR）で1,180億8,000万米ドルに成長すると予想されます。予測期間中に予想される拡大は、高齢者人口の増加、がん罹患率の増加、新興国の大きな可能性、新たな病原体の蔓延の出現、研究開発支出の増大、ヘルスケア支出の増加によるものと考えられます。予測期間中に予想される顕著な動向には、競争力を強化するための人工知能技術の導入、免疫介在性疾患の診断と個別化された治療の提供、研究開発活動への投資の増加、技術およびヘルスケア機関との協力とパートナーシップの確立が含まれます。製品ポートフォリオを強化します。

プレシジョンメディシン市場は、がんの罹患率の増加により成長が見込まれています。がんは依然として世界の主要な死因であり、5人に1人が人生のある時点でがんを発症すると予想されています。がんにおけるプレシジョンメディシンには、がんの原因となる突然変異や遺伝子異常を特定するための腫瘍DNAの検査が含まれます。これにより、医師は特定されたDNA変化を特に標的とした個別の治療法を選択できるようになります。 2022年 4月、米国がん協会は、米国における新規がん症例数が192万件と報告しました。これは、2021年の189万件からの増加を反映しており、がんの有病率がエスカレートし、プレシジョンメディシン市場の拡大を推進していることが強調されています。

プレシジョンメディシン市場の成長は、ヘルスケアへの支出の増加によってさらに促進されています。ヘルスケア支出には、医療機器、病院サービス、医師サービス、処方薬、公衆衛生活動などのヘルスケア製品およびサービスへの財政投資の総額が含まれます。この財政的取り組みは、プレシジョンメディシンの開発、導入、主流のヘルスケアへの統合を進めるために非常に重要です。たとえば、2023年 5月に国家統計局は、英国のヘルスケア支出が名目で9.4%増加し、実質で9.7%増加したと報告しました。 2021年の総ヘルスケア費は518億4,000万米ドル（396億ポンド）の医薬品支出を含む3,672億5,000万米ドル（2,807億ポンド）に達しており、ヘルスケア費の増加がプレシジョンメディシン市場の主要な原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のプレシジョンメディシン市場、テクノロジー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ビッグデータ分析
  • バイオインフォマティクス
  • 遺伝子配列決定
  • 創薬
  • コンパニオン診断
  • その他のテクノロジー
  • 世界のプレシジョンメディシン市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 腫瘍学
  • 呼吸器疾患
  • 中枢神経系疾患
  • 免疫学
  • 遺伝病
  • その他の用途
  • 世界のプレシジョンメディシン市場、最終用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 製薬会社
  • 診断会社
  • ヘルスケアおよびIT企業
  • その他の最終用途

第7章 地域および国の分析

  • 世界のプレシジョンメディシン市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のプレシジョンメディシン市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • プレシジョンメディシン市場の競合情勢
  • プレシジョンメディシン市場の企業プロファイル
    • Quest Diagnostics
    • Thermo Fisher Scientific Inc.
    • Roche Holding AG
    • Medtronic plc
    • Novartis AG

第31章 その他の大手および革新的な企業

  • Pfizer Inc.
  • Qiagen
  • AstraZeneca plc.
  • Abbott Laboratories
  • Nordic Bioscience A/S
  • Takeda Pharmaceutical Company Ltd.
  • Otsuka Pharmaceutical Co. Ltd.
  • Daiichi Sankyo
  • China National Pharmaceutical Group Co., Ltd.
  • GE Healthcare
  • Randox Laboratories
  • Almac Group
  • Sun Pharma
  • Nichi-Iko Pharmaceutical Co., Ltd.
  • Daewoong Pharmaceutical Co.,Ltd

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14890

Precision medicine refers to a form of medical treatment that involves the prevention, detection, or treatment of diseases based on an individual's genetic or protein-related information. In order to identify the most effective treatment for an individual, precision medicine takes into account factors such as their genetics, environment, and lifestyle.

The primary technologies associated with precision medicine include bioinformatics, big data analytics, drug discovery, gene sequencing, companion diagnostics, and others. Bioinformatics technologies utilize computational tools to organize, analyze, understand, visualize, and store information related to biological macromolecules. Precision medicine is applied in various medical fields, including oncology, respiratory diseases, central nervous disorders, immunology, and genetic diseases. It is implemented across different sectors, including pharmaceuticals, diagnostic companies, healthcare, and IT firms.

The precision medicine market research report is one of a series of new reports from The Business Research Company that provides precision medicine market statistics, including precision medicine industry global market size, regional shares, competitors with a precision medicine market share, detailed precision medicine market segments, market trends and opportunities, and any further data you may need to thrive in the precision medicine industry. This precision medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The precision medicine market size has grown rapidly in recent years. It will grow from $73.11 billion in 2023 to $81.06 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The rise observed in the historical period can be ascribed to a higher incidence of cancer, an escalating prevalence of mental health disorders, a heightened occurrence of respiratory diseases, augmented funding, a growing geriatric population, an upsurge in pharmaceutical research and development expenditure, and an expansion in healthcare expenditure.

The precision medicine market size is expected to see strong growth in the next few years. It will grow to $118.08 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The expansion anticipated in the forecast period can be credited to the rising geriatric population, a growing prevalence of cancer, the substantial potential of emerging economies, the emergence of new pathogenic infestations, escalating research and development spending, and an increase in healthcare expenditure. Prominent trends expected in the forecast period encompass the adoption of artificial intelligence technologies to enhance competitiveness, providing diagnosis and personalized treatment for immune-mediated diseases, increased investment in research and development activities, and the establishment of collaborations and partnerships with technology and healthcare entities to enhance product portfolios.

The precision medicine market is anticipated to experience growth due to the increasing prevalence of cancer. Cancer remains a major global cause of death, with one in five individuals expected to develop the disease at some point in their lives. Precision medicine in cancer involves the examination of tumor DNA to identify mutations or genetic abnormalities contributing to cancer. This enables physicians to select personalized treatments that specifically target the identified DNA alterations. In April 2022, the American Cancer Society reported 1.92 million new cancer cases in the US, reflecting a rise from 1.89 million cases in 2021, underscoring the escalating prevalence of cancer and driving the precision medicine market's expansion.

The growth of the precision medicine market is further driven by the increasing expenditure on healthcare. Healthcare expenditure encompasses the total financial investment in healthcare goods and services, including medical equipment, hospital services, physician services, prescription drugs, and public health activities. This financial commitment is crucial for advancing the development, adoption, and integration of precision medicine into mainstream healthcare. For example, in May 2023, the Office for National Statistics reported a 9.4% increase in nominal and a 9.7% increase in real terms in healthcare spending in the UK. With the total healthcare expenditure reaching $367.25 billion (£280.7 billion) in 2021, including pharmaceutical expenditure of $51.84 billion (£39.6 billion), the rising healthcare expenditure is a key driver for the precision medicine market.

Partnerships and acquisitions among precision medicine companies are on the rise, enabling them to broaden their scope in both oncology and non-oncology domains. Continuous research and development in precision medicine are driving innovation and expanding treatment options for chronic diseases. An example is Foundation Medicine Inc.'s partnership with Epic in August 2021, aiming to integrate comprehensive genomic profiling and testing devices with Epic's electronic medical record. This collaboration streamlines access to genomic insights for oncologists and extends the reach of precision medicine to a larger population.

Ongoing research and development in precision medicine are facilitating the adoption of novel approaches and the expansion of treatment strategies for chronic diseases. Harvard Medical School and Clalit Research Institute, in a joint precision medicine research initiative launched in August 2021, are focused on translating data insights into frontline clinical interventions. This initiative includes the establishment of the first precision medicine clinic dedicated to identifying tailored therapies for patients unresponsive to standard treatments.

In April 2021, Servier Laboratories, a France-based pharmaceutical company, acquired Agios Pharmaceuticals Inc.'s commercial, clinical, and research-stage oncology portfolio for an undisclosed amount. This strategic acquisition strengthens Servier Laboratories' presence in the malignant technology market, offering potential long-term growth in the solid tumor space. The transaction encompasses marketed oncology precision medicine in malignant technology and a clinical oncology pipeline featuring multiple early-stage and phase-3 assets. Agios Pharmaceuticals, a US-based company, specializes in developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism through the growth factor pathway.

Major companies operating in the precision medicine market report are Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic PLC, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd., GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc., Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Hypermarcas, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, Uniao Quimica

North America was the largest region in the precision medicine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the precision medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The precision medicine market consists of sales of imatinib, personalized medicine, and individualized medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Precision Medicine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on precision medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for precision medicine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The precision medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Technology: Big Data Analytics; Bioinformatics; Gene Sequencing; Drug Discovery; Companion Diagnostics; Other Technology
  • 2) By Application: Oncology; Respiratory Diseases; Central Nervous System Disorders; Immunology; Genetic Diseases; Other Applications.
  • 3) By End-Use: Pharmaceutical Companies; Diagnostic Companies; Healthcare And IT Firms; Others
  • Companies Mentioned: Quest Diagnostics; Thermo Fisher Scientific Inc.; Roche Holding AG; Medtronic plc; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Precision Medicine Market Characteristics

3. Precision Medicine Market Trends And Strategies

4. Precision Medicine Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Precision Medicine Market Size and Growth

  • 5.1. Global Precision Medicine Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Precision Medicine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Precision Medicine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Precision Medicine Market Segmentation

  • 6.1. Global Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Other Technology
  • 6.2. Global Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Immunology
  • Genetic Diseases
  • Other Applications
  • 6.3. Global Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Companies
  • Diagnostic Companies
  • Healthcare And IT Firms
  • Other End-Uses

7. Precision Medicine Market Regional And Country Analysis

  • 7.1. Global Precision Medicine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Precision Medicine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Precision Medicine Market

  • 8.1. Asia-Pacific Precision Medicine Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Precision Medicine Market

  • 9.1. China Precision Medicine Market Overview
  • 9.2. China Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Precision Medicine Market

  • 10.1. India Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Precision Medicine Market

  • 11.1. Japan Precision Medicine Market Overview
  • 11.2. Japan Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Precision Medicine Market

  • 12.1. Australia Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Precision Medicine Market

  • 13.1. Indonesia Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Precision Medicine Market

  • 14.1. South Korea Precision Medicine Market Overview
  • 14.2. South Korea Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Precision Medicine Market

  • 15.1. Western Europe Precision Medicine Market Overview
  • 15.2. Western Europe Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Precision Medicine Market

  • 16.1. UK Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Precision Medicine Market

  • 17.1. Germany Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Precision Medicine Market

  • 18.1. France Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Precision Medicine Market

  • 19.1. Italy Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Precision Medicine Market

  • 20.1. Spain Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Precision Medicine Market

  • 21.1. Eastern Europe Precision Medicine Market Overview
  • 21.2. Eastern Europe Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Precision Medicine Market

  • 22.1. Russia Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Precision Medicine Market

  • 23.1. North America Precision Medicine Market Overview
  • 23.2. North America Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Precision Medicine Market

  • 24.1. USA Precision Medicine Market Overview
  • 24.2. USA Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Precision Medicine Market

  • 25.1. Canada Precision Medicine Market Overview
  • 25.2. Canada Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Precision Medicine Market

  • 26.1. South America Precision Medicine Market Overview
  • 26.2. South America Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Precision Medicine Market

  • 27.1. Brazil Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Precision Medicine Market

  • 28.1. Middle East Precision Medicine Market Overview
  • 28.2. Middle East Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Precision Medicine Market

  • 29.1. Africa Precision Medicine Market Overview
  • 29.2. Africa Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Precision Medicine Market Competitive Landscape And Company Profiles

  • 30.1. Precision Medicine Market Competitive Landscape
  • 30.2. Precision Medicine Market Company Profiles
    • 30.2.1. Quest Diagnostics
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Roche Holding AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Medtronic plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Precision Medicine Market Other Major And Innovative Companies

  • 31.1. Pfizer Inc.
  • 31.2. Qiagen
  • 31.3. AstraZeneca plc.
  • 31.4. Abbott Laboratories
  • 31.5. Nordic Bioscience A/S
  • 31.6. Takeda Pharmaceutical Company Ltd.
  • 31.7. Otsuka Pharmaceutical Co. Ltd.
  • 31.8. Daiichi Sankyo
  • 31.9. China National Pharmaceutical Group Co., Ltd.
  • 31.10. GE Healthcare
  • 31.11. Randox Laboratories
  • 31.12. Almac Group
  • 31.13. Sun Pharma
  • 31.14. Nichi-Iko Pharmaceutical Co., Ltd.
  • 31.15. Daewoong Pharmaceutical Co.,Ltd

32. Global Precision Medicine Market Competitive Benchmarking

33. Global Precision Medicine Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Precision Medicine Market

35. Precision Medicine Market Future Outlook and Potential Analysis

  • 35.1 Precision Medicine Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Precision Medicine Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Precision Medicine Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer